Literature DB >> 10093003

The sensitivity of the lactulose/rhamnose gut permeability test.

M A van Nieuwenhoven1, B J Geerling, N E Deutz, F Brouns, R J Brummer.   

Abstract

BACKGROUND: The lactulose/rhamnose (L/R) intestinal permeability test is widely used. However, different quantities and proportions of lactulose and rhamnose are used. The aim of this study was to determine whether a low dosage of lactulose is able to discriminate between normal and increased permeability.
MATERIALS AND METHODS: Two groups of 10 healthy subjects were studied. In group 1, three different iso-osmolar test solutions were administered on 3 days. The solutions consisted of 10 g of L with 1 g of R, 5 g of L with 0.5 g of R and 1 g of L with 0.1 g of R in 65 mL of water. Group 2 ingested these solutions 1 h after ingestion of 750 mg of chenodeoxycholeic acid (CDCA), which is known to increase permeability. The urinary L/R ratio was determined using high-performance liquid chromatography. Data are presented as medians (range).
RESULTS: In group 1, no differences were observed between the three solutions. In Group 2, there was a significant difference (P = 0.045) between the three solutions. The L/R ratios were 0.0079 (0.0024-0.0152) (1L to 0.1R), 0.0138 (0.0066-0.0192) (5L to 0.5R) and 0.0144 (0.0074-0.0374) (10L to 1R). The L/R ratio differed significantly between Groups 1 and 2 (P < 0.001) using the 5L to 0.5R and 10L to 1R solutions respectively.
CONCLUSION: If the permeability is increased, the urinary L/R ratio depends on the quantity of lactulose and rhamnose administered in equal proportion. 5L to 0.5R is sufficient to discriminate between a normal and a moderately increased permeability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10093003     DOI: 10.1046/j.1365-2362.1999.00421.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

1.  Development and validation of a method for simultaneous separation and quantification of 5 different sugars in canine urine.

Authors:  J M Steiner; D A Williams; E M Moeller
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

Review 2.  Methods to determine intestinal permeability and bacterial translocation during liver disease.

Authors:  Lirui Wang; Cristina Llorente; Phillipp Hartmann; An-Ming Yang; Peng Chen; Bernd Schnabl
Journal:  J Immunol Methods       Date:  2015-01-13       Impact factor: 2.303

3.  A systematic review: Role of dietary supplements on markers of exercise-associated gut damage and permeability.

Authors:  Sarah Chantler; Alex Griffiths; Jamie Matu; Glen Davison; Adrian Holliday; Ben Jones
Journal:  PLoS One       Date:  2022-04-13       Impact factor: 3.240

4.  Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability.

Authors:  Ivana R Sequeira; Roger G Lentle; Marlena C Kruger; Roger D Hurst
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

5.  Effects of Supplementation of the Synbiotic Ecologic® 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial.

Authors:  E Wilms; J Gerritsen; H Smidt; I Besseling-van der Vaart; G T Rijkers; A R Garcia Fuentes; A A M Masclee; F J Troost
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 6.  Intestinal permeability in a patient with liver cirrhosis.

Authors:  Jonathan Manuel Aguirre Valadez; Liliana Rivera-Espinosa; Osvely Méndez-Guerrero; Juan Luis Chávez-Pacheco; Ignacio García Juárez; Aldo Torre
Journal:  Ther Clin Risk Manag       Date:  2016-11-18       Impact factor: 2.423

7.  Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.

Authors:  Martijn J L Bours; Hilde J Bos; Jon B Meddings; Robert-Jan M Brummer; Piet A van den Brandt; Pieter C Dagnelie
Journal:  BMC Gastroenterol       Date:  2007-06-19       Impact factor: 3.067

8.  The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.

Authors:  Nalan Kayhan; Benjamin Funke; Lars Oliver Conzelmann; Harald Winkler; Stefan Hofer; Jochen Steppan; Heinfried Schmidt; Hubert Bardenheuer; Christian-Friedrich Vahl; Markus A Weigand
Journal:  Crit Care       Date:  2008-10-13       Impact factor: 9.097

Review 9.  Migraine associated with gastrointestinal disorders: review of the literature and clinical implications.

Authors:  Saskia van Hemert; Anne C Breedveld; Jörgen M P Rovers; Jan P W Vermeiden; Ben J M Witteman; Marcel G Smits; Nicole M de Roos
Journal:  Front Neurol       Date:  2014-11-21       Impact factor: 4.003

10.  Bacterial translocation and in vivo assessment of intestinal barrier permeability in rainbow trout (Oncorhynchus mykiss) with and without soyabean meal-induced inflammation.

Authors:  Peyman Mosberian-Tanha; Margareth Øverland; Thor Landsverk; Felipe E Reveco; Johan W Schrama; Andries J Roem; Jane W Agger; Liv T Mydland
Journal:  J Nutr Sci       Date:  2016-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.